ストックスクリーナーアプリを入手
173.00
1.24%
2.12
アフターアワーズ：
173.00
Neurocrine Biosciences Inc (NBIX) 最新ニュース
Understanding Momentum Shifts in (NBIX) - Stock Traders Daily
Neurocrine Biosciences (NBIX) Stock Looks Reasonable At Today’s Price - simplywall.st
Is Neurocrine Biosciences (NBIX) Still Undervalued Or Does Its P E Leave Little Upside? - simplywall.st
NEUROCRINE BIOSCIENCES, INC. : WELLS FARGO RAISES TARGET PRICE TO $200 FROM $175 - Bitget
Price to sales forward of Neurocrine Biosciences, Inc. – NASDAQ:NBIX - TradingView
NBIX Maintained by Wells Fargo -- Price Target Raised to $200 - GuruFocus
Wells Fargo Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Raises Target Price to $200 - Moomoo
Should Strong Earnings Projections and Zacks Rank #1 Status Require Action From Neurocrine Biosciences (NBIX) Investors? - simplywall.st
Zacks.com featured highlights include NVIDIA, Neurocrine Biosciences and Ball - The Globe and Mail
Neurocrine Biosciences (NASDAQ:NBIX) Fits the Growth at a Reasonable Price Mold of Peter Lynch Screening - ChartMill
BofA Securities Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Announces Target Price $199 - Moomoo
Neurocrine Biosciences Inc (NBIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Can Neurocrine (NBIX) Run Higher on Rising Earnings Estimates? - Yahoo Finance
Neurocrine Price Target Raised to $200.00/Share From $155.00 by Truist Securities - Moomoo
NBIX Maintained by BMO Capital -- Price Target Raised to $170 - GuruFocus
Form 4 Neurocrine Biosciences Inc For: 13 July By Investing.com - Investing.com Nigeria
Neurocrine Biosciences chief legal officer sells $1.79m in stock - Investing.com UK
Neurocrine Biosciences chief legal officer sells $1.79m in stock By Investing.com - Investing.com South Africa
[Form 4] NEUROCRINE BIOSCIENCES INC Insider Trading Activity - Stock Titan
Neurocrine Biosciences (NBIX) officer exercises options, sells 4,367 shares - Stock Titan
Truist Financial Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Announces Target Price $200 - Moomoo
Truist raises Neurocrine Bio stock price target on pipeline potential - Investing.com
Truist raises Neurocrine Bio stock price target on pipeline potential By Investing.com - Investing.com Nigeria
Wedbush Lifts Price Target on Neurocrine Biosciences to $185 From $176, Keeps Outperform Rating - Moomoo
Reasons why investors should consider betting on Neurocrine stock - MSN
Neurocrine Biosciences (NBIX) Posts Strong Q1 Results, Is More Upside Still Left? - simplywall.st
Neurocrine Biosciences Inc (NASDAQ:NBIX) Scores High in Affordable Growth Screen - ChartMill
NEUROCRINE BIOSCIENCES INC (NBIX) Stock Chart - ChartMill
Form 144 NEUROCRINE BIOSCIENCES For: 10 July By Investing.com - Investing.com South Africa
Form 144 NEUROCRINE BIOSCIENCES For: 10 July - Investing.com India
[144] NEUROCRINE BIOSCIENCES INC SEC Filing - Stock Titan
3 Reasons Why Growth Investors Shouldn't Overlook Neurocrine (NBIX) - Yahoo Finance
Neurocrine Shares Hit Highs on Sales Spike, Strong Pipeline - Yahoo Finance
Did Neurocrine’s (NBIX) CRENESSITY Push Into Infants Just Recast Its Rare-Disease Strategy? - simplywall.st
Neurocrine Biosciences Insider Sold Shares Worth $2,603,112, According to a Recent SEC Filing - Moomoo
Neurocrine Biosciences chief regulatory officer sells $2.6m stock By Investing.com - Investing.com India
Neurocrine Biosciences chief regulatory officer sells $2.6m stock - Investing.com
Form 4 Neurocrine Biosciences Inc For: 9 July By Investing.com - Investing.com South Africa
Neurocrine (NBIX) officer sells 14,571 shares under Rule 10b5-1 plan - Stock Titan
Form 144 NEUROCRINE BIOSCIENCES For: 9 July By Investing.com - Investing.com Nigeria
1.74%
大文字化:
|
ボリューム (24 時間):